News
Gouvernance News
Luc Boblet joins 4Moving Biotech as its Chief Executive Officer
Event News
The 18th Annual Conference of the International Society of OsteoArthritis Imaging
Financial News Press Release
4Moving Biotech dans la dernière édition de Biotec Finances
Clinical Trial Gouvernance News Press Release
4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial intraarticular Liraglutide for knee osteoarthritis patients
News
4Moving Biotech at Eular Congress
Governance News
4Moving Biotech has been selected as one of the top 100 startups to invest in 2024
End of content